Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures.
Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures.
Zoledronate for the Prevention of Bone Loss in Women Discontinuing Denosumab Treatment. A Prospective 2-Year Clinical Trial.
Zoledronate for the Prevention of Bone Loss in Women Discontinuing Denosumab Treatment. A Prospective 2-Year Clinical Trial.
Efficacy and safety of denosumab vs.bisphosphonates in postmenopausal women previously treated with oral bisphosphonates.
Efficacy and safety of denosumab vs.bisphosphonates in postmenopausal women previously treated with oral bisphosphonates.
Denosumab or romosozumab therapy and risk of cardiovascular events in patients with primary osteoporosis: Systematic review and meta- analysis.
Denosumab or romosozumab therapy and risk of cardiovascular events in patients with primary osteoporosis: Systematic review and meta- analysis.
A multicenter, randomized, rater-blinded, parallel-group, phase 3 study to compare the efficacy, safety, and immunogenicity of biosimilar RGB-10 and reference once-daily teriparatide in patients with osteoporosis.
A multicenter, randomized, rater-blinded, parallel-group, phase 3 study to compare the efficacy, safety, and immunogenicity of biosimilar RGB-10 and reference once-daily teriparatide in patients with osteoporosis.
Psychotropic medications and proton pump inhibitors and the risk of fractures in the teriparatide versus risedronate VERO clinical trial.
Psychotropic medications and proton pump inhibitors and the risk of fractures in the teriparatide versus risedronate VERO clinical trial.
Algorithm for the Use of Biochemical Markers of Bone Turnover in the Diagnosis, Assessment and Follow-Up of Treatment for Osteoporosis.
Algorithm for the Use of Biochemical Markers of Bone Turnover in the Diagnosis, Assessment and Follow-Up of Treatment for Osteoporosis.
Multi-Material Dual Gradient 3D Printing for Osteogenic Differentiation and Spatial Segregation.
Multi-Material Dual Gradient 3D Printing for Osteogenic Differentiation and Spatial Segregation.
Long term effects on biochemical bone markers of a single infusion of zoledronic acid in Paget disease of bone.
Long term effects on biochemical bone markers of a single infusion of zoledronic acid in Paget disease of bone.
